Levonorgestrel intrauterine device in uterine leiomyomatosis-related hypermenorrhea

Authors

  • Luis Tang Médico Ginecólogo Obstetra; Médico del staff y coordinador de Ginecología y Obstetricia, Clínica Santa Isabel, Lima, Perú
  • Verónica Kong Médico Cirujano; Médicina General, Hospital Naval, Lima, Perú

DOI:

https://doi.org/10.31403/rpgo.v56i216

Abstract

Objectives: To determine benefits of levonorgestrel intrauterine device (IUD) in uterine leiomyomatosis associated with hypermenorrhea. Design: Descriptive, retrospective study. Participants: Women with uterine leyomiomatosis and hypermenorrhea. Interventions: Levonorgestrel IUD was applied to 15 patients with uterine leiomyomatosis and hypermenorrhea as an alternative to usual surgical treatment. Patients with 2 to 5 cm average diameter leiomyomas not localized within the cavity were included, at most 4 in number, and followed for 12 months. Main outcome measures: Reduction of both leiomyoma size and menstrual volume. Results: One  patient expelled the IUD at 3 months from insertion. In 8 of the remaining 14 (57,1%) there was reduction of the leiomyoma size between 25 and 50% in relation to the original size; in 5 patients (35,7%) the size remained the same and in one (7,1%) it grew. Menstrual volume decreased statistically significant in 85,7% (12 of the 14 patients) including amenorrhea in two. Only one patient (7,1%) reported increase in menstrual volume. Conclusions: The study group was small but may serve for considering levonorgestrel IUD as an alternative to surgical treatment in patients with leiomyomata associated to hypermenorrhea.

Downloads

Download data is not yet available.

Published

2015-04-21

How to Cite

Tang, L., & Kong, V. (2015). Levonorgestrel intrauterine device in uterine leiomyomatosis-related hypermenorrhea. The Peruvian Journal of Gynecology and Obstetrics, 56(4), 306–309. https://doi.org/10.31403/rpgo.v56i216

Issue

Section

Comunicación Corta